Nasolin (Xylometazoline Hydrochloride)

Xylometazoline Hydrochloride acts as a selective α‑adrenergic agonist. By stimulating α1 and α2 receptors on nasal blood vessels, it causes vasoconstriction, which decreases blood flow to the nasal lining, reduces edema, and opens the airway for easier breathing.

The dosage of Nasolin is determined by a qualified healthcare professional. Typically, adults are advised to administer one or two sprays per nostril, not exceeding the recommended maximum daily frequency, but the exact regimen should follow the prescriber’s instructions.

Safety data for Xylometazoline Hydrochloride during pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should consult their physician before using Nasolin to weigh potential benefits against unknown risks.

To order Nasolin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Nasolin’s active ingredient, Xylometazoline Hydrochloride, belongs to the imidazoline class, offering rapid vasoconstriction similar to phenylephrine‑based sprays. Compared with oxymetazoline, it has a comparable onset but may have a slightly shorter duration, making it suitable for short‑term relief when used as directed.

Store Nasolin at room temperature, below 25 °C. Keep the bottle in its original packaging, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

Nasolin is applied topically to each nostril using the spray pump. The user should gently blow the nose, tilt the head slightly forward, insert the nozzle into the nostril, and press the pump to deliver the recommended number of sprays.

Serious risks include rebound congestion (rhinitis medicamentosa) after prolonged use, severe hypertension, cardiac arrhythmias, and rare allergic reactions such as rash or angioedema. If any of these occur, discontinue use and seek medical attention promptly.

Nasolin should be avoided by individuals with known hypersensitivity to Xylometazoline or any excipients, patients with uncontrolled hypertension, severe coronary artery disease, or those taking monoamine oxidase inhibitors. Children under six years of age should not use it unless specifically directed by a healthcare professional.